rs375709098
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 1P and 6B. PP2BS3_SupportingBP4BS1
This summary comes from the ClinGen Evidence Repository: NM_000314.8(PTEN):c.1061C>A (p.Pro354Gln) variant meets criteria to be classified as likely benign for PTEN Hamartoma Tumor syndrome in an autosomal dominant manner using modified ACMG criteria (ACMG Classification Rules Specified for PTEN Variant Curation version 3.0.0). Please see a summary of the rules and criteria codes in the “PTEN ACMG Specifications Summary” document (assertion method column). BS1: To be applied for variants with filtering allele frequency (FAF) of 0.000043 up to 0.00056 (0.0043% up to 0.056%) in gnomAD. Popmax FAF of this variant=0.0001051.BS3_P: In vitro or in vivo functional study or studies showing no damaging effect on protein function. This variant: score of 0.09 (WT-like range) on high throughput phosphatase assay (PMID:29706350).BP4: REVEL score < 0.5 (score=0.497).PP2: PTEN is defined by the PTEN Expert Panel as a gene that has a low rate of benign missense variation and where missense variants are a common mechanism of disease.Using the Bayesian point system (PMID:29300386) for this variant with conflicting evidence: 1 benign strong and 2 benign supporting = -6. 1 pathogenic supporting = 1. Total = – 5 (likely benign). LINK:https://erepo.genome.network/evrepo/ui/classification/CA000275/MONDO:0017623/003
Frequency
Consequence
NM_000314.8 missense
Scores
Clinical Significance
Conservation
Publications
- Cowden syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- PTEN hamartoma tumor syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- macrocephaly-autism syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet
- renal cell carcinomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- leiomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- activated PI3K-delta syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Bannayan-Riley-Ruvalcaba syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Lhermitte-Duclos diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Proteus-like syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- glioma susceptibility 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000314.8. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PTEN | TSL:1 MANE Select | c.1061C>A | p.Pro354Gln | missense | Exon 9 of 9 | ENSP00000361021.3 | P60484-1 | ||
| PTEN | c.1580C>A | p.Pro527Gln | missense | Exon 10 of 10 | ENSP00000509861.1 | A0A8I5KSF9 | |||
| PTEN | c.1154C>A | p.Pro385Gln | missense | Exon 10 of 10 | ENSP00000514759.2 | A0A8V8TPK6 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152018Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000817 AC: 20AN: 244884 AF XY: 0.0000756 show subpopulations
GnomAD4 exome AF: 0.000123 AC: 180AN: 1457490Hom.: 0 Cov.: 33 AF XY: 0.000119 AC XY: 86AN XY: 724668 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152018Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74252 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at